Latest Genentech Stories
BISHOPS STORTFORD, England, March 26, 2015 /PRNewswire/ -- Customer Speakers Include AstraZeneca Neuroscience iMed, Genentech, Celgene and Many Others Dotmatics
300 Students to Receive Mentorships with Scientists from Top Research Institutions and Industry, and Financial Awards to Encourage Careers in Science and Cancer Research over Three Years
DALLAS, March 19, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Lucentis (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023" market research
RnRMarketResearch.com adds “Avastin (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023” to its store. Dallas, Texas (PRWEB)
SAN DIEGO, March 16, 2015 /PRNewswire/ -- Gensignia Life Sciences, Inc., (Gensignia) a molecular diagnostics company specializing in microRNA (miRNA) signatures as cancer diagnostic
WOONSOCKET, R.I., March 12, 2015 /PRNewswire/ -- MultiCell Immunotherapeutics, Inc. (MCIT), a majority owned subsidiary of MultiCell Technologies, Inc.
Rockefeller Plaza Window Display Celebrates the Groundbreaking Work of Today's Leading Cancer Researchers NEW YORK, March 2, 2015 /PRNewswire-USNewswire/ -- A window display at Rockefeller
In patients with moderate or worse vision loss at baseline, those treated with EYLEA gained, on average, an additional full line or more on an eye chart when compared to those treated with alternative
Management Reportedly Tells Workers the Six Companies Will Drop Compass if they Vote for Union SAN FRANCISCO, Feb.
WHITE PLAINS N.Y., Feb.